Gland’s grey market premium shrinks
The grey market premium for Gland Pharma has come off sharply from Rs 185 per share to just Rs 60 per share. Market players say the company has priced its IPO aggressively which has hit sentiment in the grey market. China’s Fosun Pharma-promoted firm has set the price band at Rs 1,490-Rs 1,500 per share for its Rs 6,480-crore IPO. “Many were expecting that the issue will be price around Rs 1,300 per share,” said a broker.
Sundar Sethuraman
Much steam left in bank stock rally
The Nifty Bank index posted its biggest